Morgan Stanley’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $152K | Buy |
5,916
+1
| +0% | +$26 | ﹤0.01% | 5958 |
|
2025
Q1 | $163K | Sell |
5,915
-26
| -0.4% | -$715 | ﹤0.01% | 5822 |
|
2024
Q4 | $160K | Sell |
5,941
-1
| -0% | -$27 | ﹤0.01% | 5869 |
|
2024
Q3 | $171K | Buy |
5,942
+5,940
| +297,000% | +$171K | ﹤0.01% | 5807 |
|
2024
Q2 | $56 | Hold |
2
| – | – | ﹤0.01% | 7462 |
|
2024
Q1 | $71 | Hold |
2
| – | – | ﹤0.01% | 7410 |
|
2023
Q4 | $62 | Buy |
+2
| New | +$62 | ﹤0.01% | 7609 |
|
2022
Q1 | – | Sell |
-600
| Closed | -$16K | – | 8012 |
|
2021
Q4 | $16K | Buy |
+600
| New | +$16K | ﹤0.01% | 7299 |
|